Patients With Active Crohn's Disease: A Study of Abatacept
5/15/2007

Alabama, California, Connecticut, District of Columbia, Florida, Georgia, Illinois, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Minnesota, Missouri, Nebraska, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Washington, Argentina, Australia, Belgium, Brazil, Canada, Czech Republic, Denmark, France, Germany, India, Ireland, Italy, Korea, Mexico, Netherlands, Poland, Puerto Rico, South Africa, Spain, Switzerland, United Kingdom clinicaltrials.gov

Related Summaries